Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Bofei Wang, Jing Hang, Weiling Li & Wanqiong Yuan. (2020) Knockdown of LncRNA DLEU2 Inhibits Cervical Cancer Progression via Targeting miR-128-3p. OncoTargets and Therapy 13, pages 10173-10184.
Read now
Read now
Zhonghai Wang, Wenmin Zhang, Jinchuan Fang, Ping Xie, Miao Miao & Hongwen Yang. (2020) Circular RNA circEXOC6B Inhibits the Progression of Ovarian Cancer by Sponging miR-421 and Regulating RUS1 Expression. OncoTargets and Therapy 13, pages 8233-8243.
Read now
Read now
Xuesen Li, Na Li, Qinghui Niu, Haibin Zhu, Zhijie Wang & Qingxian Hou. (2020) Elevated Expression of miR-629 Predicts a Poor Prognosis and Promotes Cell Proliferation, Migration, and Invasion of Osteosarcoma. OncoTargets and Therapy 13, pages 1851-1857.
Read now
Read now
Articles from other publishers (20)
Dipro Mukherjee, Dibyajit Lahiri & Moupriya Nag. (2023) Therapeutic Effects of Natural Products Isolated from Different Microorganisms in Treating Cervical Cancer: A Review. Cancer Insight 1:2, pages 31-46.
Crossref
Crossref
Yasir Osman Ali Abdalla, Bavani Subramaniam, Shaik Nyamathulla, Noorasyikin Shamsuddin, Norhafiza M. Arshad, Kein Seong Mun, Khalijah Awang & Noor Hasima Nagoor. (2022) Natural Products for Cancer Therapy: A Review of Their Mechanism of Actions and Toxicity in the Past Decade. Journal of Tropical Medicine 2022, pages 1-20.
Crossref
Crossref
Parinaz Zivarpour, Elhameh Nikkhah, Parisa Maleki Dana, Zatollah Asemi & Jamal Hallajzadeh. (2021) Molecular and biological functions of gingerol as a natural effective therapeutic drug for cervical cancer. Journal of Ovarian Research 14:1.
Crossref
Crossref
Shailendra Kumar Dhar Dwivedi, Geeta Rao, Anindya Dey, Priyabrata Mukherjee, Jonathan D. Wren & Resham Bhattacharya. (2021) Small Non-Coding-RNA in Gynecological Malignancies. Cancers 13:5, pages 1085.
Crossref
Crossref
Seung-Hyeok Park, Minsun Kim, Somi Lee, Woojin Jung & Bonglee Kim. (2021) Therapeutic Potential of Natural Products in Treatment of Cervical Cancer: A Review. Nutrients 13:1, pages 154.
Crossref
Crossref
Lin Zhu, Yinan Chen, Jing Liu, Kai Nie, Yongxin Xiao & Hong Yu. (2020) MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway. Cancer Biomarkers 29:3, pages 347-357.
Crossref
Crossref
Seung Wan Son, Han Yeoung Lee, Sokviseth Moeng, Hyo Jeong Kuh, Soo Young Choi & Jong Kook Park. (2020) Participation of MicroRNAs in the Treatment of Cancer with Phytochemicals. Molecules 25:20, pages 4701.
Crossref
Crossref
Beilei Zhang, Ling Tian, Jinrong Xie, Guo Chen & Fu Wang. (2020) Targeting miRNAs by natural products: A new way for cancer therapy. Biomedicine & Pharmacotherapy 130, pages 110546.
Crossref
Crossref
Jingnan Miao, Joe M. Regenstein, Dan Xu, Dan Zhou, Haixia Li, Hua Zhang, Chunfeng Li, Junqiang Qiu & Xun Chen. (2020) The roles of microRNA in human cervical cancer. Archives of Biochemistry and Biophysics 690, pages 108480.
Crossref
Crossref
Yong-Chul Kim & Mary L. Cutler. (2020) MicroRNA-Dependent Targeting of RSU1 and the IPP Adhesion Complex Regulates the PTEN/PI3K/AKT Signaling Pathway in Breast Cancer Cell Lines. International Journal of Molecular Sciences 21:15, pages 5458.
Crossref
Crossref
Akiko Kojima-YuasaIsao Matsui-Yuasa. (2020)
Pharmacological Effects of 1′-Acetoxychavicol Acetate, a Major Constituent in the Rhizomes of
Alpinia galanga
and
Alpinia conchigera
. Journal of Medicinal Food 23:5, pages 465-475.
Crossref
Crossref
Junichiro Chikuda, Kurataka Otsuka, Iwao Shimomura, Kagenori Ito, Hiroaki Miyazaki, Ryou-u Takahashi, Masahiro Nagasaki, Yoshiki Mukudai, Takahiro Ochiya, Toshikazu Shimane, Tatsuo Shirota & Yusuke Yamamoto. (2020) CD44s Induces miR-629-3p Expression in Association with Cisplatin Resistance in Head and Neck Cancer Cells. Cancers 12:4, pages 856.
Crossref
Crossref
Muhammad Torequl Islam. (2019) A literature-based phyto-pharmacological review on A. conchigera Griff. Oriental Pharmacy and Experimental Medicine 19:4, pages 379-392.
Crossref
Crossref
Javid Sadri Nahand, Sima Taghizadeh‐boroujeni, Mohammad Karimzadeh, Sarina Borran, Mohammad Hossein Pourhanifeh, Mohsen Moghoofei, Farah Bokharaei‐Salim, Sajad Karampoor, Amir Jafari, Zatollah Asemi, Alireza Tbibzadeh, Afshin Namdar & Hamed Mirzaei. (2019) microRNAs: New prognostic, diagnostic, and therapeutic biomarkers in cervical cancer. Journal of Cellular Physiology 234:10, pages 17064-17099.
Crossref
Crossref
Mei Zhao, Ni Chen, Xuelian Li & Ling Lin. (2019) MiR‐629 regulates hypoxic pulmonary vascular remodelling by targeting FOXO3 and PERP. Journal of Cellular and Molecular Medicine 23:8, pages 5165-5175.
Crossref
Crossref
Guoqiang Yan, Chenyao Li, Yuhang Zhao, Meng Yue & Lei Wang. (2019) Downregulation of microRNA‑629‑5p in colorectal cancer and prevention of the malignant phenotype by direct targeting of low‑density lipoprotein receptor‑related protein 6. International Journal of Molecular Medicine.
Crossref
Crossref
Bufeng Zhuang & Youshuang Cheng. (2019) MicroRNA‑629 inhibition suppresses the viability and invasion of non‑small cell lung cancer cells by directly targeting RUNX3. Molecular Medicine Reports.
Crossref
Crossref
Shailima Rampogu, Doneti Ravinder, Smita Pawar & Keun Lee. (2018) Natural Compound Modulates the Cervical Cancer Microenvironment—A Pharmacophore Guided Molecular Modelling Approaches. Journal of Clinical Medicine 7:12, pages 551.
Crossref
Crossref
Jinlai Lu, Shuirong Lu, Jingze Li, Qi Yu, Lang Liu & Qin Li. (2018)
MiR-629-5p
promotes colorectal cancer progression through targetting CXXC finger protein 4
. Bioscience Reports 38:4.
Crossref
Crossref
Chao-hua Mo, Li Gao, Xiao-fei Zhu, Kang-lai Wei, Jing-jing Zeng, Gang Chen & Zhen-bo Feng. (2017) The clinicopathological significance of UBE2C in breast cancer: a study based on immunohistochemistry, microarray and RNA-sequencing data. Cancer Cell International 17:1.
Crossref
Crossref